Filter
288
Filtered Results: 288
Text search:
pharma
company
Featured
Recommendations
12
New Publications
77
Language
Document type
No document type
152
Studies & Reports
71
Guidelines
31
Manuals
12
Strategic & Response Plan
11
Fact sheets
4
Training Material
3
Situation Updates
3
Resource Platforms
1
Countries / Regions
South Africa
14
India
14
Kenya
13
Global
12
Zimbabwe
11
Ethiopia
11
Ghana
8
Tanzania
8
Uganda
8
Nepal
7
Sierra Leone
7
Nigeria
7
Malawi
7
Western and Central Europe
7
Philippines
6
Bangladesh
5
Namibia
5
Botswana
5
Zambia
5
Rwanda
4
Eastern Europe and Central Asia
4
Ukraine
3
Liberia
3
Myanmar / Burma
3
Lesotho
2
Benin
2
Senegal
2
Burkina Faso
2
Mongolia
2
Haiti
2
Latin America and the Carribbean
2
Eastern Europe
2
Eswatini/ Swaziland
2
North Macedonia
1
Tajikistan
1
Thailand
1
Serbia
1
China
1
Kazakhstan
1
Syria
1
Kyrgyzstan
1
Uzbekistan
1
Malaysia
1
Mozambique
1
Armenia
1
Cambodia
1
Germany
1
Congo, Democratic Republic of
1
South–East Asia Region
1
Argentina
1
Papua New Guinea
1
Russia
1
Sudan
1
Georgia
1
Mali
1
Indonesia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
142
Guidelines
38
Studies & Reports
20
Policies
19
Pharmacy & Technologies
5
Maternal Health
4
HIV & STI
4
Neonatal Care
4
Reproductive Health
4
Paediatrics
3
Pediatrics
3
Policies & Guidelines HIV & TB
3
Capacity Building
3
Other
3
Gynaecology & Obstetrics
3
Non-communicable Diseases
3
Laboratory Quality Assurance
3
Global Health
3
TB
3
Family Planning
2
Diabetes
2
COVID-19
2
Pharmaceutical Assessments
2
Medical Devices & Equipment
2
Statistics
2
WASH
2
Surgery & Anaesthesia
2
Primary Health Care
2
Hepatitis
1
Child Health
1
Community Health
1
Cancer Treatment & Resources
1
Infection Control & Prevention (IPC)
1
Public Health
1
Snakebites
1
Vaccine-preventable Diseases
1
Cardiovascular Diseases
1
Women & Child Health
1
Community Health
1
Respiratory Infections
1
Health Systems
1
Women & Child Health
1
NTDs & Others
1
Parasitology
1
Water
1
Age & Elderly
1
Disease Prevention & Control
1
Toolboxes
Country specific
12
Reports & Studies
8
Quality Assurance
7
Pharmacy Practice
6
Waste Managment
6
Essential Medicines
5
Clinical Aspects, Treatment & Prevention
4
Treatment & Prevention
4
International
4
Studies
4
Prices and Patents
4
Supply Chain & Store Management
4
Antiretroviral Treatment ART
4
Adults
3
General
3
Country Specific
3
Falsified & Substandard
3
Pharmacy Management
3
Clinical Aspects & Diagnosis
3
Prevention & Strategies
3
Drug resistant TB
3
Assessment
3
Agriculture & Veterinary
2
Europe
2
Prevention & Control
2
Children & Adolescents
2
Opportunistic Infections
2
Global Impact: Socio-economic, health services, TB & HIV
2
Communication Material
2
Fair Allocation & Ethical Aspects
2
Self-care
2
Pharmaceutical Assessments
2
Traditional & Herbal Medicines
2
Pharmacovigilance
2
Health Financing Toolbox
2
Prevention & Strategies
2
Human Rights & the Right to Health
2
Research & Access
2
Alcohol
1
ART Drug Resistance
1
Local Action
1
General Reports
1
Surveillance
1
Children with Disabilities
1
IPC
1
Background PTSD in children
1
Preparedness, Response & Risk Communication
1
Introduction to Global Health
1
Schizophrenia
1
Influenza
1
Stroke
1
Concepts of Global Health
1
Curricula & Core Competencies
1
General Studies & Reports
1
TB
1
Tools for Rational use
1
Advocacy
1
Training
1
Sustainable Development Goals
1
IEC Substance Use Disorders
1
Clinical Guidelines
1
Health Personnel
1
Public Health
1
Diagnostics & Laboratory Guidance
1
Country specific documents
1
Hospital Readiness/Essential Health Services
1
Blood Supply
1
RCCE Guides & Manuals
1
Access & Strategy
1
Gambling
1
TB/HIV
1
Research & Pipeline
1
Hygiene
1
Primary Care
1
Triage
1
Climate Change General
1
Food environments
1
Essential Medicines & Devices Lists
1
Model Formulary
1
Rational use of Medicine
1
Resuscitation
1
Epilepsy
1
Health Care Systems
1
Antimicrobial Resistance (AMR)
1
Studies & Reports
1
Overview, Studies & Reports
1
Yaws & other Endemic Treponematoses
1
Studies & Reports
1
Risk Factors
1
Women
1
Global Overview
1
Neurological Disorders
1
Alzheimer's Disease & Dementia
1
General
1
Assessment & Response
1
Malawi
1
Training
1
Tuberculosis
1
Prevention of mother-to-child transmission (PMTCT)
1
Self-harm & Suicide
1
Uganda
1
Vision Loss & Blindness
1
General Public
1
TB/HIV Coinfection
1
Tobacco
1
Anxiety Disorders
1
Global Health Institutions and Stakeholders
1
Overview & Statistics
1
Lobby and Advocacy
1
Eastern Europe & Central Asia
1
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covid-19 vaccines. This report updates that assessment ...
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac...
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May and June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA tea...
An evaluation of the prescribing patterns for under-five patients at a Tertiary Paediatric Hospital in Sierra Leone. J Basic Clin Pharma 2015;6:109-14.
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o...
Southern Med Review (2009)2;1:2-6
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Medicines and Health Products Price and Availability Monitoring Mobile Application. This tool fac...
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control Council’s current thinking on the safety, quality and efficacy of medicines.
